<DOC>
	<DOCNO>NCT02918045</DOCNO>
	<brief_summary>The purpose study compare two hemostatic agent patient dual antiplatelet therapy use intraoral bleeding time dental extraction .</brief_summary>
	<brief_title>Dental Extractions Patients Under Dual Antiplatelet Therapy</brief_title>
	<detailed_description>Postoperative hemostasis fundamental patient management issue oral maxillofacial surgery setting . The risk excessive bleeding prompt physicians stop multiple antiplatelet agent minor surgery , put coronary stenting patient risk adverse thrombotic event . Adequate hemostasis must achieve order make oral surgery possible patient without discontinuation antiplatelet regimen . The HemCon Dental Dressing ( HemCon Medical Technologies , Inc , Beaverton , OR ) novel chitosan-based hemostatic agent may greatly improve upon efficacy wound heal hemostasis extent time minor oral surgery . Dental extraction perform patient dual antiplatelet therapy without alter medication regimen . All patient require two surgical site internal surgical control sit . Cutaneous bleeding time platelet aggregation test obtain prior extraction . The primary hemostasis evaluate measure intraoral bleeding time extraction bleed heal outcome ascertain phone questionaires clinical evaluation . The aim study evaluate effectiveness HemCon Dental Dressing control post extraction bleed ascertain role heal extraction wound compare standard haemostasis method .</detailed_description>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<mesh_term>Chitosan</mesh_term>
	<mesh_term>Cellulose , Oxidized</mesh_term>
	<criteria>Patients require two dental extraction procedure . Patients must dual antiplatelet therapy kind . Patients must 18 year age old . Patients must available minimum one post operative evaluation schedule time procedure approximately 7 day post surgery . Extraction sit require primary closure suture . Willingness ability provide inform consent Patients currently undertake anticoagulant medication ( e.g. , aspirin , coumadin , heparin ) discontinue anticoagulant medication . History heart attack le 1 week . Patients seafood allergy . Unable unwilling provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tooth Extraction</keyword>
	<keyword>Surgical Hemostasis</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Chitosan</keyword>
</DOC>